UHS UNIVERSAL HEALTH SERVICES INC
Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 352915 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.0%
TTM net income YoY6.3%
TTM EPS YoY13.7%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR29.3%
Margins
Gross margin—
Operating margin10.8%
Net margin8.0%
FCF margin6.1%
EBITDA margin14.5%
Returns
ROE19.8%
ROA9.0%
ROIC (approx.)12.2%
Asset turnover1.13x
Leverage & solvency
Liabilities / assets55.0%
Debt / equity0.75x
Current ratio1.37x
Interest coverage11.34x
Cash quality & payout
Operating cash flow / net income1.41x
Accruals ratio-3.7%
Payout ratio3.3%
Capex / revenue5.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4.73B | $4.64B | $4.50B | $4.49B | $4.50B | $4.28B | $4.10B | $4.11B |
| Operating income | $454.45M | $516.67M | $502.86M | $517.23M | $521.69M | $500.27M | $454.82M | $472.49M |
| Interest expense | $56.28M | $39.91M | $37.13M | $42.22M | $38.43M | $35.36M | $40.06M | $39.72M |
| Pretax income | $413.91M | $479.13M | $469.12M | $581.44M | $496.89M | $473.38M | $420.43M | $438.31M |
| Income tax | $100.58M | $114.54M | $110.44M | $133.60M | $117.78M | $110.77M | $98.80M | $101.26M |
| Net income | $308.68M | $358.45M | $348.68M | $445.94M | $372.96M | $353.22M | $316.68M | $332.40M |
| EBITDA | $629.29M | $684.01M | $658.29M | $680.57M | $676.75M | $652.27M | $603.17M | $619.27M |
| EPS (basic) | 5.25 | 6.01 | 5.71 | — | 5.92 | 5.49 | 4.87 | — |
| EPS (diluted) | 5.22 | 5.98 | 5.65 | — | 5.86 | 5.43 | 4.80 | — |
| Dividends declared per share | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Weighted avg. shares (diluted) | 59.15M | 59.91M | 61.67M | — | 63.66M | 64.99M | 66.04M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $168.75M | $138.80M | $119.03M | $137.80M | $112.89M | $137.59M | $126.75M | $125.98M |
| Receivables | $2.81B | $2.80B | $2.75B | $2.60B | $2.59B | $2.30B | $2.41B | $2.18B |
| Current assets | $3.68B | $3.68B | $3.50B | $3.41B | $3.26B | $2.99B | $3.08B | $2.82B |
| PP&E, net | $7.22B | $7.14B | $7.06B | $7.01B | $6.97B | $6.88B | $6.70B | $6.57B |
| Goodwill | $4.74B | $3.98B | $3.98B | $3.99B | $3.99B | $3.98B | $3.95B | $3.93B |
| Intangibles | — | — | — | $75.88M | — | — | — | $76.27M |
| Total assets | $17.19B | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B |
| Current liabilities | $2.69B | $3.30B | $3.24B | $3.24B | $3.16B | $2.32B | $2.33B | $2.21B |
| Short-term debt | $79.81M | $771.91M | $756.24M | $748.16M | $740.19M | $40.90M | $40.41M | $40.06M |
| Long-term debt | $5.63B | $4.08B | $3.95B | $4.00B | $3.95B | $4.54B | $4.61B | $4.46B |
| Total debt | $5.71B | $4.85B | $4.71B | $4.75B | $4.69B | $4.58B | $4.65B | $4.50B |
| Total liabilities | $9.44B | $8.28B | $8.08B | $8.12B | $8.05B | $7.84B | $7.99B | $7.71B |
| Shareholders' equity | $7.60B | $7.51B | $7.46B | $7.28B | $7.17B | $7.03B | $6.79B | $6.67B |
| Net debt | $5.54B | $4.71B | $4.59B | $4.61B | $4.58B | $4.45B | $4.52B | $4.38B |
| Cash flow statement | ||||||||
| Operating cash flow | $636.56M | $443.30M | $401.63M | $574.69M | $380.68M | $548.98M | $360.05M | $658.44M |
| Capital expenditure | $214.94M | $227.63M | $217.16M | $281.22M | $228.89M | $266.01M | $239.03M | $245.94M |
| Free cash flow | $421.61M | $215.67M | $184.47M | $293.47M | $151.79M | $282.96M | $121.02M | $412.49M |
| Investing cash flow | -$1.21B | -$234.23M | -$197.58M | -$223.97M | -$269.41M | -$305.94M | -$271.30M | -$207.99M |
| Financing cash flow | $605.73M | -$189.49M | -$221.89M | -$296.13M | -$134.52M | -$227.65M | -$91.42M | -$426.76M |
| Depreciation & amortization | $174.84M | $167.34M | $155.43M | $163.33M | $155.06M | $152.00M | $148.34M | $146.78M |
| Stock-based compensation | $26.36M | $22.91M | $22.50M | $25.10M | $24.88M | $24.11M | $21.59M | $26.62M |
| Dividends paid | $11.79M | $11.79M | $12.97M | $12.37M | $12.47M | $12.90M | $13.53M | $13.04M |
| Share buybacks | $245.26M | $320.75M | $163.85M | $352.01M | $237.40M | $155.16M | $223.38M | $250.17M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.